Identifying Optimal Assessment Tools for RSV & Other Respiratory Illnesses
Researchers identified optimal assessment tools for RSV, influenza, and hMPV that accurately supplement the identification of well-being and disease burden.
Read More
Respiratory Syncytial Virus
Disparities Impact RSV Vaccination Uptake in Adults Aged 60 & Older
Just over a fifth of US adults aged 60 and older had been vaccinated against RSV as of March 2024, with disparities seen by race/ethnicity and age.
Read More
Q&A: Assessing RSV as a Newly Vaccine-Preventable Disease
Fiona P. Havers, MD, MHS, spoke with Physician’s Weekly about managing RSV as a newly vaccine-preventable disease now that multiple vaccines have been approved.
Read More
COVID-19, Flu & RSV Vaccination Remains Low in Nursing Homes
According to CDC data, COVID-19, RSV, and influenza vaccination rates are low among nursing home residents early in the 2024-2025 respiratory virus season.
Read More
RSV Vaccination Prevents Hospitalization & Emergency Visits
In adults aged 60 or older, RSV vaccination is effective for preventing associated hospitalizations and ED visits, with similar effectiveness across age groups.
Read More
RSV Hospitalization Rate Highlights Unmet Medical Needs
An estimated one in 20 adults with medically attended RSV are hospitalized, with hospitalizations more likely in high-risk subgroups such as patients with COPD.
Read More
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Risk Less & Do More Aims to Increase RSV Vaccination
The national Risk Less, Do More campaign aims to raise awareness of vaccines for serious respiratory illnesses, including RSV, in high-risk groups.
Read More
Limited RSV Testing Done in Older Adults With Respiratory Symptoms
Regular RSV testing in older patients with respiratory symptoms is relatively low, and targeted efforts are needed to increase RSV testing in this group.
Read More
Update Aims to Increase RSV Vaccination Among Older Adults
Updated RSV vaccine recommendations for older adults replace last year’s guidance to simplify RSV vaccine decision-making for clinicians and the public.
Read More
RSV Contributes to Burden of Cardiorespiratory Hospitalizations
Modeling excess risk using viral positivity data provides a comprehensive estimation of RSV hospitalization burden and associated costs compared with ICD codes.
Read More
Use of Multiple Tests Improves RSV Diagnostic Yield
Paired serology testing, standard-of-care swabs, and separate testing of nasopharyngeal and oropharyngeal swabs improved RSV diagnosis in hospitalized adults.
Read More